Zhang Fa-Lei, Feng Tao
School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China.
J Fungi (Basel). 2022 Feb 28;8(3):244. doi: 10.3390/jof8030244.
Fungi have traditionally been a very rewarding source of biologically active natural products, while diterpenoids from fungi, such as the cyathane-type diterpenoids from and sp., the fusicoccane-type diterpenoids from and sp., the guanacastane-type diterpenoids from and sp., and the harziene-type diterpenoids from sp., often represent unique carbon skeletons as well as diverse biological functions. The abundances of novel skeletons, biological activities, and biosynthetic pathways present new opportunities for drug discovery, genome mining, and enzymology. In addition, diterpenoids peculiar to fungi also reveal the possibility of differing biological evolution, although they have similar biosynthetic pathways. In this review, we provide an overview about the structures, biological activities, evolution, organic synthesis, and biosynthesis of diterpenoids that have been specially produced by fungi from 2010 to 2020. We hope this review provides timely illumination and beneficial guidance for future research works of scholars who are interested in this area.
传统上,真菌一直是生物活性天然产物的一个非常有价值的来源,而来自真菌的二萜类化合物,如来自[具体物种1]和[具体物种2]的赛丹烷型二萜类化合物、来自[具体物种3]和[具体物种4]的腐壳烷型二萜类化合物、来自[具体物种5]和[具体物种6]的瓜纳卡斯坦烷型二萜类化合物以及来自[具体物种7]的哈尔齐烷型二萜类化合物,通常代表着独特的碳骨架以及多样的生物学功能。新骨架、生物活性和生物合成途径的丰富性为药物发现、基因组挖掘和酶学提供了新的机遇。此外,真菌特有的二萜类化合物也揭示了不同生物进化的可能性,尽管它们具有相似的生物合成途径。在这篇综述中,我们概述了2010年至2020年真菌特有的二萜类化合物的结构、生物活性、进化、有机合成和生物合成。我们希望这篇综述能为该领域感兴趣的学者们未来的研究工作提供及时的启发和有益的指导。